Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
B-001 by Shanghai Pharmaceutical Group for B-Cell Non-Hodgkin Lymphoma: Likelihood of Approval
B-001 is under clinical development by Shanghai Pharmaceutical Group and currently in Phase I for B-Cell Non-Hodgkin Lymphoma. According to...